ACLY-IN-2
ACLY-IN-2 (Compound 7) has inhibitory effect against human ATP citrate lyase (hACLY), with an IC50 of less than 1 nM. ACLY-IN-2 can be studied in research on liver-related diseases, type-2 diabetes, autoimmunity, and cancer[1].
Product Specifications
CAS Number
[3009136-86-8]
UNSPSC
12352101
Target
ATP Citrate Lyase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer; Metabolic Disease; Inflammation/Immunology
Smiles
O=C(C1=CC2=C(O)C(Cl)=C1)OCCOC3=CC=CC=C3C4=CC(NS2(=O)=O)=C(F)C=C4F
Molecular Formula
C21H14ClF2NO6S
Molecular Weight
481.85
References & Citations
[1]Stephen Lawrence Pinkosky, et al., Macrocyclic inhibitors of atp citrate lyase. WO2023215220A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2087-42P-PE 200 µL
Caspase 8, CT (CASP8, CASP-8, ALPS2B, Apoptotic Cysteine Protease, Apoptotic Protease Mch-5, CAP4, FADD-homologous ICE/ced-3-like Protease, FADD-like ICE, FLICE, FLJ17672, ICE-like Apoptotic Protease 5, MORT1-associated Ced-3 Homolog, MACH, MCH5, MGC78473) (PE) discontinued
Ask
View Details 
